Results 81 to 90 of about 12,798 (141)

Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability

Patient Preference and Adherence, 2017
Michael S Anderson,1 Anish Nadkarni,1 Leah A Cardwell,1 Hossein Alinia,1 Steven R Feldman1–3 1Department of Dermatology, Center for Dermatology Research, 2Department of Pathology, 3Department of Public Health Sciences, Wake Forest School of ...
Anderson MS, Nadkarni A, Cardwell LA, Alinia H, Feldman SR   +4 more
doaj  

Efficacy of Brimonidine in Preventing Intraocular Pressure Spikes following Phacoemulsification in Glaucoma Patients

, 2010
Purpose To measure intraocular pressure (IOP) elevation 6 and 24 hours after phacoemulsification in patients with glaucoma and to investigate the efficacy of brimonidine tartrate 0.2% in preventing IOP rise on the first postoperative day following ...
Dimitrios Karagiannis, Nikolaos Kyriakos, Anastasios Baxevanakis, Michalis Karampelas, Christos Panos, Artemios Kandarakis, Vasileios Soumplis   +6 more
core   +1 more source

Effect of brimonidine on anterior-chamber angle in patients with narrow angles

Philippine Journal of Ophthalmology, 2011
Objective: This study investigated the effect of brimonidine on the anterior-chamber angle in eyes with narrow angles using noncontact three-dimensional anterior-segment analyzer Pentacam.
Johanna Timoteo-Cervantes, MD, Joseph Anthony Tumbocon, MD, Ma. Margarita Lat-Luna, MD   +2 more
doaj  

Aceclidine, brimonidine tartrate, and dapiprazole: comparison of miotic effect and tolerability under different lighting conditions.

, 2008
Purpose: To evaluate the effect on pupil diameter of three different miotic eye-drops: aceclidine, brimonidine tartrate 0.20% and dapiprazole, when applied topically in normal subjects Methods: The eyes of 30 healthy volunteers were included in this ...
Benelli U, Canovetti A, NARDI, MARCO, Fogagnolo P, Benelli U., Figus M   +5 more
core  

Brimonidine/Apraclonidine: Anterior Segment Effect

, 2010
. This study investigated whether brimonidine tartrate 0.2% and/or apraclonidine 0.5% could alter pupil size and intraocular anterior segment configuration. Methods.
Besada, Eulogio, Reed, Kimberly, Shechtman,, Diana, Najman, Perla   +3 more
core   +1 more source

Novel long-acting brimonidine tartrate loaded-PCL/PVP nanofibers for versatile biomedical applications: fabrication, characterization and antimicrobial evaluation. [PDF]

RSC Adv, 2023
Salim SA, Badawi NM, El-Moslamy SH, Kamoun EA, Daihom BA.   +4 more
europepmc   +1 more source

갈색홍채에서 Brimonidine 0.15%안약 1일1회 점안이 암순응된 동공에 미치는 영향

, 2007
PURPOSE: To analyze the effect of once daily use of brimonidine tartrate 0.15% solution on the dark-adapted pupil diameter with dark brown irides. METHODS: 25 normal volunteers without any medical past history or ocular pathology administered brimonidine
노, 승수
core   +1 more source

Effect of over-the-counter brimonidine tartrate 0.025% ophthalmic solution on pupil size in healthy adults. [PDF]

Graefes Arch Clin Exp Ophthalmol, 2021
Nejad M, Lin SR, Hwang LH, Landig M, Al-Hashimi S, Bartlett JD.   +5 more
europepmc   +1 more source

Mildly Cross-Linked Dendrimer Hydrogel Prepared via Aza-Michael Addition Reaction for Topical Brimonidine Delivery

, 2017
In this work, we developed a mildly cross-linked dendrimer hydrogel (mcDH) via aza-Michael addition of polyamidoamine PAMAM dendrimer G5 and polyethylene glycol diacrylate PEG-DA, Mn = 575 g/mol .
Geoffrey S. Williamson, Hu Yang, Juan Wang, Williamson, Geoffrey S., Yang, Hu, Michael G. Lancina III, Wang, Juan, Lancina, Michael G., III   +7 more
core   +1 more source

Preparation of polymeric microspheres as an ophthalmic drug delivery system for brimonidine tartrate

, 2009
A dramatic increase in the incidence of eye diseases, such as age-related macular degeneration, and inadequate therapeutic control has led to the search for advanced methods of sustained and targeted drug delivery.
McBride, E., Wilson, C.G., Couston, R.
core   +2 more sources